Literature DB >> 3655403

Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci.

L Dall1, W G Barnes, J W Lane, J Mills.   

Abstract

The presence of abundant surface polysaccharide, or glycocalyx, on viridans streptococci has been associated with failure to eradicate the organism from experimental cardiac vegetations during penicillin treatment. The role of glycocalyx in retarding sterilization was tested by in vivo administration of dextranase, an endohydrolase that attacks internally situated alpha (1-6) linkages. Dextranase and penicillin, either singly or in combination, were used to treat experimental endocarditis. After two days of therapy, 100% of animals treated with penicillin or dextranase alone had infected vegetations, whereas only 25% treated with penicillin and dextranase had infected vegetations (P less than .01). After five days of therapy, 100% of the animals treated with penicillin had infected vegetations, versus none that were treated with penicillin and dextranase (P less than .01). We conclude that glycocalyx acts to retard antibiotic activity in vegetations and that partial enzymatic digestion of the glycocalyx facilitates penicillin sterilization of the infected valve.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3655403     DOI: 10.1093/infdis/156.5.736

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

3.  Association of cell-adherent glycocalyx and endocarditis production by viridans group streptococci.

Authors:  L H Dall; B L Herndon
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Quantitative assay of glycocalyx produced by viridans group streptococci that cause endocarditis.

Authors:  L Dall; B Herndon
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

5.  Platelet depletion and severity of streptococcal endocarditis.

Authors:  L Dall; T Miller; B Herndon; I Diez; M Dew
Journal:  Can J Infect Dis       Date:  1998-11

6.  Glucosyltransferase mediates adhesion of Streptococcus gordonii to human endothelial cells in vitro.

Authors:  A M Vacca-Smith; C A Jones; M J Levine; M W Stinson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.

Authors:  H Yasuda; Y Ajiki; T Koga; H Kawada; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.

Authors:  A S Bayer; S Park; M C Ramos; C C Nast; F Eftekhar; N L Schiller
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement.

Authors:  B Yersin; M P Glauser; P A Guze; L B Guze; L R Freedman
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis.

Authors:  H Yasuda; Y Ajiki; T Koga; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.